A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Pramipexole D3 | CAS 1217695-77-6 - Request Quote

Picture of Pramipexole D3

Pramipexole D3

SZ CAT No:SZ-P001D01
CAS No
1217695-77-6
Mol.F.
C10H14D3N3S
Mol.Wt.
214.4
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Pramipexole D3 is chemically (S)-N6-(propyl-3,3,3-d3)-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine. Pramipexole D3 is supplied with detailed characterization data compliant with regulatory guideline. Pramipexole D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pramipexole.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 1217695-77-6

Purchase 1217695-77-6

Order 1217695-77-6

Enquire 1217695-77-6

price of 1217695-77-6

1217695-77-6 Supplier

1217695-77-6 Manufacturer

1217695-77-6 Exporter

buy high quality Pramipexole D3

Purchase Pramipexole D3

Pramipexole D3 suppliers

Pramipexole D3 manufacturers

Pramipexole D3 price

Order Pramipexole D3

Enquire Pramipexole D3

Pramipexole D3 cost

Pramipexole D3 Supplier

Pramipexole D3 Distributor

Pramipexole D3 for Method Validation

Pramipexole Reference Standard

Pramipexole D3 for ANDA Filing

Pramipexole D3 for Forced Degradation Studies

Pramipexole D3 Identification Standards

Pramipexole D3 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,